Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines.
Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 700 employees.
Company Details
- Employees
- 661
- Founded
- -
- Address
- 6, Rue Alain Bombard, Saint-Herblain,pays De La Loire 44800,france
- Phone
- +33 2 28 07 37 10
- bd****@****eva.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- valneva.com
- Keywords
- vaccines.
- HQ
- Saint-Herblain, Pays de la Loire
Valneva Questions
Valneva's helpline number is +33 2 28 07 37 10
Valneva's website is valneva.com
Valneva's LinkedIn profile is https://www.linkedin.com/company/valneva
Valneva has
661 employees.
View email and phone details for 661
employees at Valneva.
Valneva's industry is
Biotechnology Research
Valneva's top competitors are
Genfit,
Xenothera,
Phaxiam Therapeutics,
Cellectis,
Ose Immunotherapeutics,
Innate Pharma,
Abivax,
Sanofi,
Limmatech Biologics Ag,
Boehringer Ingelheim.
Valneva's support email address is bd@valneva.com
Valneva's categories are Biotechnology Research
Valneva's founding year is 2013
